Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
LUNIT INC
{{company.company_channel.channel_name}}
Media Room
Latest
Photos
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Follow :
X
Company Profile
Media Room
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.title}}
loading
The End
Network Errors Please Retry
{{selectname}}
{{showName}}
{{selectall}}
{{option}}
Lunit AI Solutions to Power Samsung's X-ray Devices for Advanced Chest Screening
2024-01-16 22:04
Lunit to Acquire Volpara: Scheme Implementation Agreement Signed
2023-12-14 22:05
Lunit Advances to Stage 2 of Australia's National Breast Cancer Screening Project
2023-12-11 22:30
Lunit to Advance Singapore's Healthcare System with AI-powered Solution for Medical Imaging
2023-11-30 22:10
AI-Powered TIL Analysis by Lunit Unveils Prognostic Insights for Colon Cancer - published in npj Precision Oncology
2023-11-27 22:05
Lunit's AI-Powered Mammography Analysis Solution Proves Comparable to Radiologists in Breast Cancer Detection - published in European Radiology
2023-11-22 22:07
Lunit to Implement AI-Powered Chest Screening Solution in Five Major Saudi Hospitals
2023-11-16 22:00
Lunit Nets FDA Nod for AI-Powered 3D Breast Tomosynthesis Solution, Lunit INSIGHT DBT
2023-11-14 22:00
Lunit, a Founding Member of CancerX, Showcased in the Inaugural Project to Improve Equity and Reduce Financial Toxicity in Cancer Care
2023-11-13 22:00
Lunit to Present Seven AI-Powered Radiology Studies at RSNA 2023
2023-11-06 21:00
AI-Powered Tumor Microenvironment Analysis Predicts Treatment Outcomes in NSCLC Patients with EGFR Mutation: Groundbreaking Studies to be Presented by Lunit at SITC 2023
2023-11-01 21:08
Lunit Enters into Research Collaboration to Explore the Use of AI to Improve the Effectiveness of Immunotherapy
2023-10-27 21:07
Lunit Participates in Saudi Vision 2030 Healthcare Sandbox, Accelerating Saudi Arabia's Healthcare Transformation
2023-10-26 21:00
First Immunotherapy Success in TKI-Resistant Lung Cancer Setting Demonstrates Power of AI-driven Immune Phenotyping by Lunit SCOPE IO - newly published in JCO
2023-10-24 21:00
New Study Demonstrates Lunit SCOPE IO's Effectiveness to Predict Biliary Tract Cancer Therapy Outcomes - Findings to be Presented at the ESMO 2023
2023-10-16 21:10
Lunit to Showcase 9 AI-based Research Results at ESMO 2023
2023-10-10 21:00
Lunit to Reveal 6 Abstracts at the SITC 2023 Annual Meeting
2023-09-27 22:03
Study Validates Lunit AI as a Game-Changer, Poised to Replace One Human Reader in Breast Cancer Screening
2023-09-12 13:03
Study Validates Lunit AI as a Game-Changer, Poised to Replace One Human Reader in Breast Cancer Screening
2023-09-11 21:00
Lunit Accelerates Expansion Across Middle East by Bringing AI Solution to Dr. Sulaiman Al Habib Medical Group, Middle East's Largest Healthcare Provider
2023-07-26 14:00
1
2
3
4